10
Exp. Eye Res. (1999) 69, 75–84 Article No. exer.1999.0678, available online at http :}}www.idealibrary.com on Monoclonal IgA Antibodies Protect Against Acanthamoeba Keratitis HENRY LEHER, FERNANDO ZARAGOZA, SHERINE TAHERZADEH, HASSAN ALIZADEH JERRY Y.NIEDERKORN* Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75235-9057, U.S.A. (Received Columbia 12 November 1998 and accepted in revised form 23 February 1999) Acanthamoeba keratitis is a rare, yet sight-threatening corneal infection. Ocular infection does not appear to induce protective immunity as repeated corneal infections occur in both humans and experimental animals. However, we have recently demonstrated that activation of the common mucosal immune system by oral immunization with Acanthamoeba antigens protects both Chinese hamsters and pigs against ocular infection with A. castellanii. Protection correlates closely with the appearance of anti- Acanthamoeba antibodies in the tears. To test the hypothesis that oral immunization induces specific protective IgA antibodies, two monoclonal IgA antibodies specific for Acanthamoeba antigens were generated. Both antibodies detected epitopes on the surface of fixed Acanthamoeba trophozoites. When delivered intraperitoneally, one monoclonal antibody (14E4) was detected in stool and tear samples. This clone also protected naive animals against ocular challenge with Acanthamoeba trophozoites (43 % infection rate compared to a 91 % infection rate in animals receiving control IgA). In vitro functional studies showed that neither antibody induced encystment or directly killed Acanthamoeba trophozoites. However, both monoclonal anti-Acanthamoeba IgA antibodies produced a three-fold inhibition in the adherence of trophozoites to corneal epithelial cells in vitro. These data show that monoclonal anti- Acanthamoeba IgA antibodies can protect against Acanthamoeba keratitis and suggest that this occurs by inhibiting adhesion of the parasite to the corneal epithelium. # 1999 Academic Press Key words : Acanthamoeba ; keratitis ; monoclonal IgA ; tear ; adhesion. 1. Introduction Corneal infections have caused millions of cases of blindness (Adamis and Shein, 1994 ; Pavan-Langston, 1994). With many pathogens, adhesion of the parasite to the corneal epithelium is a crucial first step in pathogenesis (van Klink et al., 1993 ; Beving, Soong and Ravdin, 1996 ; Hocini et al., 1997 ; Fluckiger, Jones and Fischetti, 1998). Acanthamoebae are ubiquitously distributed pro- tozoal parasites known to cause the sight-threatening corneal inflammatory disease Acanthamoeba keratitis (Visvesvara and Stehr-Green, 1990). Pathogenesis probably results from contaminated contact lenses which bring the parasite into close proximity with the cornea. Adhesion of Acanthamoeba trophozoites to the corneal surface is known to be a critical first step in pathogenesis (Niederkorn et al., 1992 ; van Klink et al., 1993). In vitro analysis has shown a direct relationship between the ability of the parasite to bind to corneal epithelial cells and the ability of Acanthamoebae to produce disease in animal models (Niederkorn et al., 1992). Adhesion is species specific in that trophozoites appear to bind to corneal epithelial * To whom all correspondence should be addressed : J. Y. Niederkorn, Department of Ophthalmology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Tx. 75235-9057, U.S.A. cells from only four species : human, pig, rabbit and Chinese hamster (Niederkorn et al., 1992 ; Yang, Cao and Panjwani, 1997). Following adherence, the trophozoites elicit soluble cytolytic factors which allow the parasite to invade the stroma (Leher et al., 1998c ; He et al., 1990). Parasite-derived collagenase pro- duced inside the stroma is believed to contribute to the pathology seen in this disease (He et al., 1990). Although Acanthamoeba keratitis can be a chronic infection, therapeutic modalities have greatly improved in recent years. Acanthamoebae are known to be resistant to nu- merous topical chemotherapeutics and to several components of the immune system (Alizadeh et al., 1995 ; Alizadeh, Niederkorn and McCulley, 1996 ; van Klink et al., 1997 ; Toney and Marciano-Cabral, 1998). Our laboratory has shown that repeated intramuscular immunizations induced specific Acanthamoeba-specific serum IgG and delayed-type hypersensitivity responses, yet failed to protect against ocular challenge with Acanthamoeba trophozoites (Alizadeh et al., 1995 ; van Klink et al., 1997). Moreover, repeated ocular infections do not induce protective immunity (Alizadeh et al., 1995 ; van Klink et al., 1997). These findings parallel the human disease. Human environmental exposure to Acanthamoebae is apparently common and results in systemic immune responses against the parasite in 50–100 % of the normal adult population (Wang and 0014–4835}99}01007510 $30.00}0 # 1999 Academic Press

Monoclonal IgA Antibodies Protect Against Acanthamoeba Keratitis

Embed Size (px)

Citation preview

Exp. Eye Res. (1999) 69, 75–84Article No. exer.1999.0678, available online at http :}}www.idealibrary.com on

Monoclonal IgA Antibodies Protect Against

Acanthamoeba Keratitis

HENRY LEHER, FERNANDO ZARAGOZA, SHERINE TAHERZADEH,

HASSAN ALIZADEH JERRY Y. NIEDERKORN*

Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas,

TX 75235-9057, U.S.A.

(Received Columbia 12 November 1998 and accepted in revised form 23 February 1999)

Acanthamoeba keratitis is a rare, yet sight-threatening corneal infection. Ocular infection does not appearto induce protective immunity as repeated corneal infections occur in both humans and experimentalanimals. However, we have recently demonstrated that activation of the common mucosal immunesystem by oral immunization with Acanthamoeba antigens protects both Chinese hamsters and pigsagainst ocular infection with A. castellanii. Protection correlates closely with the appearance of anti-Acanthamoeba antibodies in the tears. To test the hypothesis that oral immunization induces specificprotective IgA antibodies, two monoclonal IgA antibodies specific for Acanthamoeba antigens weregenerated. Both antibodies detected epitopes on the surface of fixed Acanthamoeba trophozoites. Whendelivered intraperitoneally, one monoclonal antibody (14E4) was detected in stool and tear samples. Thisclone also protected naive animals against ocular challenge with Acanthamoeba trophozoites (43%infection rate compared to a 91% infection rate in animals receiving control IgA). In vitro functionalstudies showed that neither antibody induced encystment or directly killed Acanthamoeba trophozoites.However, both monoclonal anti-Acanthamoeba IgA antibodies produced a three-fold inhibition in theadherence of trophozoites to corneal epithelial cells in vitro. These data show that monoclonal anti-Acanthamoeba IgA antibodies can protect against Acanthamoeba keratitis and suggest that this occurs byinhibiting adhesion of the parasite to the corneal epithelium. # 1999 Academic Press

Key words : Acanthamoeba ; keratitis ; monoclonal IgA; tear ; adhesion.

1. Introduction

Corneal infections have caused millions of cases of

blindness (Adamis and Shein, 1994; Pavan-Langston,

1994). With many pathogens, adhesion of the parasite

to the corneal epithelium is a crucial first step in

pathogenesis (van Klink et al., 1993; Beving, Soong

and Ravdin, 1996; Hocini et al., 1997; Fluckiger,

Jones and Fischetti, 1998).

Acanthamoebae are ubiquitously distributed pro-

tozoal parasites known to cause the sight-threatening

corneal inflammatory disease Acanthamoeba keratitis

(Visvesvara and Stehr-Green, 1990). Pathogenesis

probably results from contaminated contact lenses

which bring the parasite into close proximity with the

cornea. Adhesion of Acanthamoeba trophozoites to the

corneal surface is known to be a critical first step in

pathogenesis (Niederkorn et al., 1992; van Klink et

al., 1993). In vitro analysis has shown a direct

relationship between the ability of the parasite to bind

to corneal epithelial cells and the ability of

Acanthamoebae to produce disease in animal models

(Niederkorn et al., 1992). Adhesion is species specific

in that trophozoites appear to bind to corneal epithelial

* To whom all correspondence should be addressed : J. Y.Niederkorn, Department of Ophthalmology, University of TexasSouthwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Tx.75235-9057, U.S.A.

cells from only four species : human, pig, rabbit and

Chinese hamster (Niederkorn et al., 1992; Yang, Cao

and Panjwani, 1997). Following adherence, the

trophozoites elicit soluble cytolytic factors which allow

the parasite to invade the stroma (Leher et al., 1998c;

He et al., 1990). Parasite-derived collagenase pro-

duced inside the stroma is believed to contribute to the

pathology seen in this disease (He et al., 1990).

Although Acanthamoeba keratitis can be a chronic

infection, therapeutic modalities have greatly

improved in recent years.

Acanthamoebae are known to be resistant to nu-

merous topical chemotherapeutics and to several

components of the immune system (Alizadeh et al.,

1995; Alizadeh, Niederkorn and McCulley, 1996; van

Klink et al., 1997; Toney and Marciano-Cabral,

1998). Our laboratory has shown that repeated

intramuscular immunizations induced specific

Acanthamoeba-specific serum IgG and delayed-type

hypersensitivity responses, yet failed to protect against

ocular challenge with Acanthamoeba trophozoites

(Alizadeh et al., 1995; van Klink et al., 1997).

Moreover, repeated ocular infections do not induce

protective immunity (Alizadeh et al., 1995; van Klink

et al., 1997). These findings parallel the human

disease. Human environmental exposure to

Acanthamoebae is apparently common and results in

systemic immune responses against the parasite in

50–100% of the normal adult population (Wang and

0014–4835}99}010075­10 $30.00}0 # 1999 Academic Press

76 H. LEHER ET AL.

Feldman, 1967; Cerva, 1989; Cursons et al., 1980).

Nonetheless,Acanthamoebakeratitis occurs in immuno-

competent individuals. This point is reinforced by the

recrudescent nature of this disease in humans. Infected

individuals may sustain this infection for months and

sometimes years before complete resolution of the

disease occurs (Garner, 1993; Lindquist, 1998).

Our laboratory has provided preliminary evidence

showing that activation of the common mucosal

immune system can provide protection against

Acanthamoeba keratitis (Alizadeh et al., 1995; Leher et

al., 1998a, 1998b). Pigs and Chinese hamsters orally

immunized with Acanthamoeba antigens in the pres-

ence of the mucosal adjuvant cholera toxin (CT) were

protected against ocular challenge with Acanthamoeba-

laden contact lenses (Alizadeh et al., 1995; Leher et

al., 1998a, 1998b). The orally immunized animals

produced IgA antibodies specific for Acanthamoeba

antigens (Ac-ag) which could be detected in mucosal

secretions, including tear samples (Leher et al., 1998a,

1998b). When examined functionally, IgA from orally

immunized animals inhibited the adhesion of tropho-

zoites to corneal epithelial cells in vitro (Leher et al.,

1998a, 1998b). These results strongly suggest that

anti-Acanthamoeba IgA antibodies are the mediators of

immunity against Acanthamoeba keratitis in orally

immunized animals. However, the most compelling

proof of this hypothesis is to protect susceptible animals

through the passive transfer of monoclonal IgA

antibodies specific for Acanthamoeba. Accordingly, we

developed two anti-Acanthamoeba IgA monoclonal

antibodies which recognized surface epitopes on A.

castellanii trophozoites. The capacity of these mono-

clonal antibodies to provide protection against

Acanthamoeba keratitis was tested in Chinese hamsters.

2. Materials and Methods

Animals

Chinese hamsters (Cricetulus griseus) were

purchased from Cytogen Research and Development,

Inc. (West Roxbury, MA, U.S.A.). Animals were used

when they were 4–12 weeks old. All animals were free

from corneal defects and abnormalities prior to

experiments and were handled in accordance with the

Association for Research in Vision and Ophthalmology

(ARVO) Resolution on the Use of Animals in Research.

Cell Lines

An ocular human isolate of Acanthamoeba castellanii

was acquired from American Type Culture Collection

(ATCC No. 30868, Rockville, MD, U.S.A.) and was

maintained in axenic culture at 35°C in peptone-

yeast-glucose media (PYG) as previously described

(Alizadeh et al., 1995). Complete minimal essential

medium (cMEM) is defined as follows: MEM (JRH

Biosciences, Lenexa, KS, U.S.A.) supplemented with

1% -glutamine (BioWhittaker, Walkersville, MD,

U.S.A.), 1% sodium pyruvate (BioWhittaker), 1%

MEM vitamins (BioWhittaker), and 1% penicillin,

streptomycin and fungizone (BioWhittaker) with 10%

fetal bovine serum (FBS; Hyclone Labs, Logan, UT,

U.S.A.). Chinese hamster corneal epithelial cells

(CHCE) were immortalized from a corneal explant

using the E6}E7 papilloma virus oncogene as pre-

viously described (Wilson et al., 1995). CHCE were

cultured in cMEM containing 500 µg ml−" geneticin

(Sigma, St Louis, MO, U.S.A.). Complete Dulbecco’s

modified Eagle’s medium (cDMEM) is defined as

follows: DMEM (JRH Biosciences) supplemented with

1% -glutamine (BioWhittaker), 1% sodium pyruvate

(BioWhittaker), 10 m HEPES (BioWhittaker), 1%

non-essential amino acids (BioWhittaker), and 1%

penicillin, streptomycin and fungizone (BioWhittaker)

with 15% FBS (Hyclone Labs, Logan, UT, U.S.A.).

Hybridoma cell lines were established and maintained

in cDMEM containing 0±1 m hypoxanthine, 0±4 n

aminopterin and 16 n thymidine (Sigma; HAT-

DMEM). An anti-trinitrophenol (TNP) IgA producing

hydridoma was obtained from ATCC (No. MOPC 315)

and was maintained in cDMEM. Production of anti-

TNP IgA antibodies were verified by enzyme linked

immunosorbent assay (ELISA) using microtiter plates

coated with TNP covalently linked to bovine serum

albumin (BSA) (TNP-BSA was kindly provided by Dr

Dorothy Yuan, University of Texas Southwestern

Medical Center, Dallas, TX, U.S.A.). Mouse anti-TNP

IgA gave an optical density score of 0±447³0±031 at

a 1:200 dilution compared to an irrelevant isotype

control antibody which gave an optical density of

0±086³0±0006.

Collection of Chinese Hamster Mucosal Secretions

Tear secretion was induced by intraperitoneal (IP)

administration of 24 mg kg−" pilocarpine (Sigma).

Tears were collected 10 min after pilocarpine adminis-

tration using 2 µl micro-pipettes (Drummond Scien-

tific, Broomall, PA, U.S.A.). Samples were placed into

sterile microfuge tubes and snap frozen in liquid

nitrogen prior to storage at ®80°C. Stool samples

were collected and immediately placed into phosphate

buffered saline (PBS; pH¯7±2) containing 5% BSA

(Sigma) and a single protease inhibitor cocktail tablet

(Boehringer Mannheim, Indianapolis, IN, U.S.A.).

Stool samples were centrifuged for 5 minutes in an

Eppendorf microfuge (Brinkman Instruments Inc.,

Westbury, NY, U.S.A.) at 100 g, aliquoted, and stored

at ®80°C until used.

ELISA and Western Analyses

Ninety six well microtiter plates were coated with

10 µg ml−" aqueous proteinaceous Acanthamoeba

trophozoite extract (Ac-ag) overnight in 0±1 car-

bonate buffer (Sigma; pH 9±6). Plates were washed 4

times with PBS containing 0±01% Tween-20 (Sigma;

MONOCLONAL IGA AGAINST ACANTHAMOEBA 77

wash buffer), and blocked with 5% BSA in PBS

(blocking buffer) for 1 hr at 37°C. Subsequent anti-

bodies were diluted in blocking buffer. Concentrated

culture supernatant containing either monoclonal

anti-Acanthamoeba IgA antibodies or anti-TNP control

IgA antibodies were added undiluted, 1:10, 1:100 or

1:200. Mucosal fluids were diluted as follows: stool

samples were diluted 1:1. Tears were diluted from

1:100 to 1:800 using two-fold serial dilutions.

Samples were incubated for 1 hr at 37°C. Rabbit anti-

Chinese hamster IgA hyperimmune sera (Leher et al.,

1998a) was added (1:100) and the plates incubated

at 4°C for 2 hr. Plates were washed and 1:10000 goat

anti-rabbit IgG-horse radish peroxidase (HRP) (Ac-

curate, San Diego, CA, U.S.A.) was added. Plates were

developed by adding 1±0 m 2,2«-azinobis(3-ethyl-

benzthiazoline-6-sulfonic acid) (Sigma) containing

0±003% H#O#

and incubated for 30 min at room

temperature. After development, 0±1 ml of 10% SDS

(Sigma) was added per well prior to reading on a

microplate reader (Molecular Devices Corp.) at

405 nm. Naive tears produced an optical density of

0±418³0±008 for all dilutions (1:100 through

1:3200), suggesting a nonspecific uniform back-

ground. The mean optical density obtained from each

dilution of naive tears was subtracted from the same

dilutions of experimental tears. Likewise, naive stool

samples produced a background optical density of

0±305³0±016 which was subtracted from the optical

densities obtained from experiment samples.

Western blot analysis of culture supernatant was

carried out using conventional techniques. Briefly,

25 µg of protein were resolved on a 12% reducing

SDS-polyacrylamide (SDS-PAGE) gel using a BioRad

minigel apparatus (BioRad, Hercules, CA, U.S.A.). Gels

were transferred to Immobilon-P nylon membranes

(Millipore) using a BioRad minitransfer apparatus as

per the manufacturer’s recommendations. Blots were

blocked for 1 hr with 5% casein (Sigma) in PBS with

shaking prior to addition of rabbit anti-Chinese

hamster IgA immune sera diluted 1:100 in the same.

After 1 hr, membranes were washed again and

1:1000 goat anti-rabbit IgG-HRP in PBS containing

5% casein was added. The membrane was incubated

for 1 hr, washed, and developed using an ECL Western

blotting kit (Amersham, Buckinghamshire, U.K.) as

per the manufacturer’s instructions. Monomeric,

dimeric, and polymeric IgA were determined by

comparison with molecular weight standards and

comparison with a well-characterized control mono-

clonal anti-TNP IgA antibody (ATCC MOPC 315)

which is known to produce monomeric and polymeric

IgA (Weltzin et al., 1989).

Chinese Hamster Acanthamoeba Keratitis

Ocular infection with Acanthamoeba was achieved

by placing parasite-laden contact lenses onto scarified

eyes. Briefly, contact lenses were fashioned from

dialysis tubing (Spectrum Med. Inc., Houston, TX,

U.S.A.) using a 3 mm trephine. Lenses were sterilized

in a contact lens heat sterilizer prior to overnight

incubation in PYG containing 50% trophozoites and

50% cysts (3¬10' Acanthamoebae ml−"). Hamsters

were anesthetized by intramuscular injection of

10 mg kg−" ketamine (Ft. Dodge Laboratories Inc., Ft.

Dodge, IA, U.S.A.) and a topical application of

proparacaine (Alcaine, Alcon, Ft. Worth, TX, U.S.A.).

Corneas were gently abraded (25% of surface) using a

sterile cotton swab. Parasite-laden lenses were placed

on the abraded corneas and eyes were closed with a

single suture (6.0 Ethilon, Johnson and Johnson,

Somerville, NJ, U.S.A.). The lenses were removed 7

days later and the infection scored on a scale of 0–5

based on the following parameters : corneal infil-

tration, corneal neovascularization, and corneal ul-

ceration. The pathology was recorded as follows: 0¯no pathology, 1¯!10% of the cornea involved, 2¯10–25%, 3¯25–50%, 4¯50–75%, and 5¯75–

100%. Any animal receiving a score of at least 1±0 for

any parameter was scored as infected.

Production of Chinese Hamster Anti-Acanthamoeba

IgA Monoclonal Antibodies

Hamsters were lightly anesthetized by methoxy-

flurane (Metofane, Mallinckrodt Veterinary Inc.,

Mundelein, IL, U.S.A.) inhalation. Animals received

0±25 ml of 0±1 sodium carbonate (Sigma; pH 9±6) by

gavage prior to oral administration of 10 µg of CT

mixed with 100 µg of Ac-CT in a total volume of

100 µl. All oral immunizations were performed by

gavage once per week for 4 weeks.

Those animals which demonstrated anti-Acantha-

moeba IgA in stool samples by ELISA and were

protected against ocular challenge with Acanthamoeba-

laden contact lenses were selected as B-cell donors.

Peyer’s patches collected from the orally immunized

hamsters were minced with scissors prior to filtration

through nylon mesh (Nitex, Tetko Inc., Kansas City,

MO, U.S.A.). The cells were washed 3¬ in cDMEM

and mixed with mouse myeloma cells (X63Ag8.653,

kindly provided by Dr Philip Thorpe, UT Southwestern

Medical Center, Dallas, TX, U.S.A.) at a ratio of 4:1.

The cells were centrifuged at 500 g and resuspended

in 0±5 ml of 50% polyethylene glycol with 10%

dimethylsulfoxide (Sigma). The fused cells were diluted

in serum-free cDMEM, centrifuged at 100 g, and

resuspended to 10' cells ml−" in cDMEM containing

0±5¬ hypoxanthine, aminopterin and thymidine

(HAT) media supplement (HAT-cDMEM). One hundred

microliters of the cellular suspension were placed into

96-well plates containing Chinese hamster peritoneal

exudate cells (feeder layers). Cultures were fed every 3

days with fresh HAT-cDMEM until colonies were

visible in the wells.

Supernatants collected from growth positive wells

were tested for the presence of anti-Acanthamoeba IgA

78 H. LEHER ET AL.

F. 1. Western analysis of anti-Acanthamoeba IgA monoclonal antibodies. Concentrated hybridoma culture supernatantswere resolved on 12% SDS-PAGE gels loaded at 25 µg lane−". The gels were transferred to nylon membranes and Westernanalysis performed using rabbit anti-Chinese hamster IgA hyperimmune sera. The secondary antibody was goat anti-rabbit IgG-HRP and the blot was developed by ECL Western blotting kit. The lanes contained the following concentrated culturesupernatants : Lane 1¯ anti-Acanthamoeba IgA (clone 14E4) ; Lane 2¯ anti-Acanthamoeba IgA (clone F6C3) ; Lane 3¯ anti-TNP mouse IgA (Control IgA) ; and Lane 4¯ concentrated fresh media (Media). Bracket A indicates region of dimeric andpolymeric forms of IgA and bracket B indicates monomeric IgA based on comparisons with molecular weight standards andcontrol anti-TNP IgA (Lane 3).

by ELISA as described above. Growth positive wells

producing anti-Acanthamoeba IgA were recultured into

three 96-well plates, and the process repeated, until

90% of the growth positive wells were also positive for

anti-Acanthamoeba IgA. Selected wells were subjected

to limiting dilution to isolate monoclonal lines. Two

cell lines, each originating from different primary

wells, were expanded (clones 14E4 and F6C3).

Hybridomas producing anti-Acanthamoeba or con-

trol anti-TNP IgA were cultured in cDMEM-HAT or

cDMEM respectively. Cultures were grown until the

media were exhausted. The cells were then removed

by centrifugation at 250 g (Jouan CR-412, Jouan,

Inc., Winchester, VA, U.S.A.). Culture supernatants

were concentrated to one-tenth the original volume

and dialyzed using a Filtron Ultrasette concentrator

(Pall-Filtron, Northborough, MA, U.S.A.) containing a

10 kDa exclusion membrane as per the manu-

facturer’s recommendations. The supernatants were

further concentrated on a 100 kDa Filtron (Pall-

Filtron) microcentrifugal concentrator prior to storage

at ®80°C.

Passive Immunization of Chinese Hamsters with Anti-

Acanthamoeba IgA

Chinese hamsters received 2±0 mg (0±5 ml) of

concentrated monoclonal antibody culture super-

natant containing either anti-Acanthamoeba IgA 14E4

or F6C3, or anti-TNP IgA. The supernatants were

concentrated as described above and administered i.p.

twice per day for 7 days (i.e., 14 injections). The

animals received ocular Acanthamoeba infections as

described above 6 days after the last immunization.

MONOCLONAL IGA AGAINST ACANTHAMOEBA 79

Seven days after receiving Acanthamoeba-laden contact

lenses, the ocular infections were scored by two

independent, masked observers.

Adhesion Assay and Immunofluorescent Staining of

Trophozoites

Adhesion of Acanthamoeba trophozoites to CHCE in

vitro was carried out by radiolabeling 2¬10'

trophozoites ml−" overnight in 0±1 µCi $&S-

methionine}cysteine (New England Nuclear, Boston,

MA, U.S.A.). The labeled parasites were washed 3¬ in

HBSS (BioWhittaker) and resuspended (1¬10'

trophozoites ml−") in HBSS containing 1:400 or

1:800 of one of the following concentrated culture

supernatants : anti-Acanthamoeba IgA clone 14E4,

anti-Acanthamoeba IgA clone F6C3, or control mouse

anti-TNP IgA monoclonal antibody. Trophozoites were

mixed with IgA preparations (100 µl well−") and then

added to a 96-well plate containing confluent CHCE

monolayers. Cultures were incubated at 35°C for 45

minutes, and then washed 3¬ with the HBSS. One

hundred microliters of 10% SDS were added and the

plates were incubated 15 min at room temperature

prior to transferring the well’s contents to scintillation

vials. Counts were measured on a Beckman LS3801

scintillation counter (Beckman, Irvine, CA, U.S.A.). All

samples were tested in quadruplicate.

Immunofluorescent staining of trophozoites was

performed as follows. Trophozoites were washed 3¬with HBSS prior to a 1-hr fixation in ice-cold acetone

(EM Science, Darmstadt, Germany). The fixed tropho-

zoites were washed three times and resuspended to

1¬10' trophozoites ml−" in PBS containing 5% BSA

(blocking buffer; Sigma) for 1 hr. A 1:50 dilution of

concentrated culture supernatant from one of the

following hybridoma cell lines was added to 0±1 ml of

trophozoite suspension: anti-Acanthamoeba IgA clone

14E4; anti-Acanthamoeba IgA clone F6C3; or control

mouse anti-TNP IgA. Following incubation for 1 hr on

ice, a 1:50 dilution of rabbit anti-Chinese hamster IgA

was added. Trophozoites were washed and incubated

for 1 hr with goat anti-rabbit IgG-FITC (1:1,000;

Accurate). Trophozoites were washed and then

visualized with a Leica Diaplan microscope (Deerfield,

IL, U.S.A.) using a 40¬ epiflourescence objective.

Images were captured using a CCD camera (COHU,

San Diego, CA, U.S.A.) with an integrator}storer

(Colorado Video Inc., Boulder, CO, U.S.A.) and digitized

using a Data Translator DT3155 image-acquisition

card (Data Translation, Marlboro, MA, U.S.A.) on a

DELL pentium computer.

IgA-mediated Cytotoxicity Assay

Acanthamoeba castellanii trophozoites were washed

3¬ in HBSS and resuspended to 1¬10& tropho-

zoites ml−" in a 1:400 dilution of one of the following

concentrated culture supernatants : anti-Acanthamoeba

IgA clone 14E4, anti-Acanthamoeba IgA clone F6C3, or

control mouse anti-TNP IgA monoclonal antibody.

After 1, 4 or 8 hr, trophozoite suspensions were

diluted 1:2 in trypan blue and examined micro-

scopically for viability and encystment. All samples

were tested in triplicate and the average numbers of

viable trophozoites were reported with standard

deviation of the mean.

Statistical Analysis

Statistical analyses were carried out using a

Student’s t test.

3. Results

Monoclonal Anti-Acanthamoeba IgA Antibodies

Previous studies in our laboratory have shown that

oral immunization using CT and Ac-ag protected

against Acanthamoeba keratitis (Alizadeh et al., 1995;

Leher et al., 1998a, 1998b). Protection correlated

with the appearance of anti-Acanthamoeba IgA in the

tears (Leher et al., 1998a, 1998b). If tear IgA

antibodies were the protective entity induced by oral

immunization, then passive transfer of monoclonal

IgA antibodies specific for Acanthamoeba antigens

should protect naive hamsters from Acanthamoeba

keratitis. Accordingly, two monoclonal anti-

F. 2. Monoclonal anti-Acanthamoeba IgA antibodies arespecific for Acanthamoeba antigen. ELISA plates were coatedwith 10 µg ml−" Ac-ag overnight. Concentrated monoclonalantibody culture supernatants were diluted 1:10, 1:100, or1:200 and added to the wells. Rabbit anti-Chinese hamsterIgA was added as a second step, and after incubation, wasfollowed with goat anti-rabbit IgA-HRP. The ELISA plateswere developed and read at 405 nm. Data are the mean oftriplicate wells and are reported as mean optical density³..*P!0±0007 by Student’s t test. These results are from onerepresentative experiment. This experiment was performedthree times with similar results. *, Media Control ; V, IgAControl ; D, 14E4 Anti-Acanthamoeba IgA; -, F6C3 Anti-Acanthamoeba IgA.

80 H. LEHER ET AL.

F. 3. Anti-Acanthamoeba IgA monoclonal antibodies bind to fixed trophozoites. Trophozoites were fixed in ice-cold acetoneand incubated with either rabbit anti-Acanthamoeba hyperimmune sera (Hyperimmune sera), mouse anti-TNP IgA (ControlIgA), or anti-Acanthamoeba IgA (14E4 or F6C3). The cells were washed and incubated with rabbit anti-Chinese hamster IgAprior to exposure to goat anti-rabbit IgG-FITC. Photographs are representative of at least ten high-power fields per sample.

Acanthamoeba IgA antibodies (14E4 and F6C3) were

generated. Limiting dilution was performed twice to

insure that each selected cell line was monoclonal.

Because monomeric IgA is not readily transported to

the mucosal surface (Hexham, Carayannopoulos and

Capra, 1997), concentrated culture supernatants were

examined by Western analysis to determine whether

the monoclonal antibodies were produced as mono-

meric or polymeric IgA. Each clone produced mono-

meric, dimeric, and polymeric forms of the antibody

(Fig. 1). The mouse control IgA hybridoma also

produced monomeric and polymeric forms of antibody;

however staining on the Western blot was weaker

than the hamster IgA antibodies due to the limited

capacity of the rabbit anti-hamster IgA antibody to

cross-react with mouse IgA (Fig. 1). Analysis by ELISA

showed that both anti-Acanthamoeba antibodies bound

to Acanthamoeba antigens while anti-trinitrophenol

(TNP) control IgA antibodies did not (Fig. 2). More-

over, both anti-Acanthamoeba monoclonal antibodies

bound to epitopes on fixed trophozoites, while anti-

TNP IgA control antibodies did not (Fig. 3).

Effects of Passively Transferred Anti-Acanthamoeba

IgA Against Acanthamoeba Keratitis

To examine the ability of the monoclonal IgA

antibodies to protect against Acanthamoeba keratitis,

the following antibody preparations were administered

to three separate groups of hamsters : (1) anti-

Acanthamoeba IgA (clone 14E4), (2) anti-Acanthamoeba

IgA (clone F6C3), or (3) mouse anti-TNP IgA (control

IgA). Each animal received 2±0 mg of concentrated

antibody culture supernatant i.p. twice per day. The

MONOCLONAL IGA AGAINST ACANTHAMOEBA 81

F. 4. Passively transferred anti-Acanthamoeba IgAappears in mucosal secretions. Hamsters were passivelyimmunized with (1) anti-Acanthamoeba IgA clone 14E4, (2)anti-Acanthamoeba IgA clone F6C3, or (3) mouse anti-TNPcontrol IgA. Two-milligrams of antibody preparation wereadministered twice daily for 7 days. (A) Stool (n¯4) and (B)tear samples (n¯7) were collected on day 5 and assayed forthe presence of anti-Acanthamoeba IgA by ELISA. Back-ground optical densities produced by naive stools or tearsranged from 0±305³0±016 to 0±418³0±008 and weresubtracted from the respective experimental samples. Eachsample was tested separately. Optical densities for eachgroup were combined and reported as mean opticaldensity³.. of the mean. Statistics were carried out usingStudent’s t test. *P%0±03 compared to animals receivingcontrol IgA. These data are from a typical experiment whichwas performed two times with similar results. *, 14E4 Anti-Acanthamoeba IgA; V, F6C3 Anti-Acanthamoeba IgA; D,Control IgA.

injections were administered for 7 consecutive days

and the animals were challenged with ocular

Acanthamoeba infections on day 6 of the immunization

protocol.

To insure that the antibodies were present at

mucosal sites, stool and tear samples were collected 1

day before infection and examined for the presence of

anti-Acanthamoeba IgA by ELISA. Anti-Acanthamoeba

IgA from clone 14E4 was present in both stool and

tear samples in significant quantities compared to

samples taken from naive animals or animals receiving

control IgA [Fig. 4(A) and (B)]. Surprisingly, tear

F. 5. Anti-Acanthamoeba IgA protects againstAcanthamoeba keratitis. Hamsters were passively immunizedwith (1) anti-Acanthamoeba IgA clone 14E4, (2) anti-Acanthamoeba IgA clone F6C3, or (3) mouse anti-TNPcontrol IgA. Two-milligrams of antibody preparation wereadministered twice daily for 7 days. On day 6, the animalswere infected with Acanthamoeba-laden contact lenses. Thecontact lenses were removed 7 days later and infection rateswere scored. The data show the infection rates for eachgroup. The infected}total number of animals and severityscores for each group were as follows: Control IgA (10}11animals were infected; combined severity score of 1±42);14E4 (6}14 animals were infected; combined severity scoreof 0±36); and F6C3 (15}17 animals were infected; combinedseverity of 1±55).

samples collected from animals given anti-

Acanthamoeba IgA clone F6C3 showed only a trace

amount of anti-Acanthamoeba IgA, which was not

significantly higher than control animals. No anti-

Acanthamoeba IgA was found in stool samples from

animals receiving clone F6C3 [Fig. 4(A) and (B)].

Seven days after infection with Acanthamoeba-laden

contact lenses, the clinical disease of the animals was

scored. A compilation of two experiments showed the

infection rate of Chinese hamsters receiving anti-

Acanthamoeba IgA clone 14E4 was 42±8% compared to

animals given control IgA (90±0%) or those receiving

anti-Acanthamoeba IgA clone F6C3 (88±2%; Fig. 5).

Function of Anti-Acanthamoeba IgA

As shown above, anti-Acanthamoeba IgA protected

over 40% of the naive Chinese hamsters against

ocular challenge with Acanthamoeba trophozoites. We

next sought to examine the functional characteristics

of the monoclonal antibodies in vitro. Anti-

Acanthamoeba IgA antibody might function to prevent

corneal disease by either killing the trophozoites,

inducing their encystment, or preventing their ad-

herence to the corneal epithelium. Accordingly, the

82 H. LEHER ET AL.

F. 6. The effects of anti-Acanthamoeba IgA monoclonalantibody on trophozoite viability. Trophozoites wereincubated with anti-Acanthamoeba IgA monoclonal antibody(clone 14E4 or F6C3), anti-TNP mouse IgA, or HBSS (Media)for 1, 4 or 8 hr. At each time point the parasites werecollected and examined microscopically for viability bytrypan blue staining. Viability was not significantly differentat any time point when compared to trophozoites treatedwith control IgA or media alone. The data are from arepresentative experiment which was repeated once withsimilar results. ,, Media; 7, Control IgA; , 14E4 Anti-Acanthamoeba IgA; , F6C3 Anti-Acanthamoeba IgA.

anti-Acanthamoeba IgA monoclonal antibodies were

examined for their effect on parasite viability and

adherence to corneal epithelial cells in vitro. The

results showed that neither of the anti-Acanthamoeba

IgA antibodies killed trophozoites (Fig. 6) or induced

their encystment in vitro (data not shown). However,

as shown in Fig. 7, both anti-Acanthamoeba IgA

monoclonal antibodies inhibited binding of tropho-

zoites to Chinese hamster corneal epithelial cells

(CHCE). Nearly three-fold fewer trophozoites incubated

in anti-Acanthamoeba IgA bound to CHCE than

parasites preincubated in either medium or control

anti-TNP IgA.

4. Discussion

Herpes simplex virus keratitis and trachoma are

responsible for millions of cases of blindness (Adamis

and Shein 1994; Pavan-Langston, 1994). Both can

result in devastating immune-mediated corneal de-

struction. Like most mucosal parasites, adherence to

epithelial surfaces is the first step in the infectious

cascade (Adamis and Shein, 1994; Pavan-Langston,

1994). In numerous parasitic infections, disrupting

this first step in the infectious process has a profound

effect on pathogenesis. Numerous studies have shown

that viral, bacterial and amoebic infections can be

diminished or prevented by specific IgA antibodies

which inhibit adhesion between the pathogen and the

F. 7. Anti-Acanthamoeba IgA monoclonal antibodyinhibits adhesion of trophozoites to corneal epithelial cells invitro. Radiolabelled trophozoites were incubated with eitheranti-Acanthamoeba IgA (clone 14E4 or F6C3), anti-TNPmouse IgA (control IgA), or media. The parasites wereplaced into 96-well plates containing confluent CHCEmonolayers. After 45 minutes incubation the cells werewashed and the remaining counts measured. Adherenttrophozoites are represented as mean counts per minute(CPM)³.. Data are the mean of 4 wells per sample andstatistical analyses were carried out using Student’s t test. *The number of trophozoites preincubated in anti-Acanthamoeba IgA were significantly different from all othergroups (P%0±0031). The data are from a representativeexperiment which was repeated two times with similarresults.

affected host mucosal surface (Beving et al., 1996;

Hocini et al., 1997; Fluckiger et al., 1998; Leher et al.,

1998a, 1998b).

The importance of parasite adhesion has been

demonstrated in the pathogenesis of Acanthamoeba

keratitis. Yang et al. (1997) have shown that a

136 kDa mannose binding lectin mediates adhesion of

Acanthamoeba trophozoites to corneal epithelial cells.

As stated earlier, adherence is critical as trophozoites

can only induce disease in species in which the

parasite can bind to the cornea (Niederkorn et al.,

1992). IgA antibodies, the sentinels of humoral

defense at mucosal surfaces, often act by interfering

with adhesion of pathogens to mucosal epithelium.

Animal models of Acanthamoeba keratitis have pro-

vided a reproducible model in which to examine the

role of mucosal immunity in the form of IgA antibodies

against corneal parasitic challenges.

The present study showed that passive transfer of

anti-Acanthamoeba IgA monoclonal antibodies pro-

MONOCLONAL IGA AGAINST ACANTHAMOEBA 83

tected a significant percentage of naive Chinese

hamsters against ocular infection with Acanthamoeba

trophozoites. Both antibodies (14E4 and F6C3) recog-

nized epitopes from proteinaceous trophozoite extracts

and on the surface of the trophozoites. Furthermore,

the antibodies were shown to be functional by their

ability to inhibit adhesion of trophozoites to corneal

epithelial cells in vitro. Only one of the two monoclonal

antibodies (14E4) was protective upon passive transfer

into naive Chinese hamsters. Curiously, 14E4 was

present at the mucosal surface while the other anti-

Acanthamoeba IgA, F6C3, was not. One likely ex-

planation is that 14E4 was able to bind to the

polyimmunoglobulin receptor, the receptor protein

required for translocation of polymeric IgA onto a

mucosal site (Hexham et al., 1998). Because both

antibodies were the result of a fusion procedure which

produced cells containing chromosomes from each cell

type, it is possible that a recombination event mutated

F6C3 such that it could no longer bind to the

polyimmunoglobulin receptor. Myeloma cells, the

fusion partner used to create these hybridomas, are

known to actively recombine exogenously introduced

deoxyribonucleic acid (Fell et al., 1989). A recom-

bination event may lead to loss, addition, or re-

placement of amino acids which could subsequently

impede attachment of polymeric IgA to the poly-

immunoglobulin receptor. Nevertheless, one antibody

(14E4) successfully passed onto the mucosal surface

and was protective against Acanthamoeba keratitis.

These data demonstrate that multimeric IgA anti-

bodies delivered i.p. can appear at mucosal surfaces

including the cornea. Masinick et al. (1997) have also

shown that functional IgA can be induced to appear at

the corneal surface. Direct experiments suggesting a

mechanism whereby IgA functions at the corneal

surface have not been conducted; however, it seems

likely that the IgA antibodies are present in association

with the mucinous tear layer (Hazlett, Wells and Berk,

1981; Wells and Hazlett, 1985). IgA immobilized in

this fashion would be available to recognize infectious

agents, incarcerate them on the corneal surface, and

render them susceptible for removal by the shear

forces of the blink reflex. Such a mechanism of

protection is advantageous because nonspecific inflam-

matory cells such as neutrophils would not respond.

Thus, injury to bystander tissues, produced by non-

specific inflammation, would be averted.

Collateral damage inflicted by inflammatory

responses are responsible for much of the blinding

pathology associated with such diseases as HSV-

keratitis and trachoma (Adamis and Shein, 1994;

Pavan-Langston, 1994). Because IgA antibodies are

not strongly associated with inflammatory responses,

immunization procedures which stimulate IgA anti-

bodies provide a different form of protection than

conventional immunization. A growing body of evi-

dence has demonstrated the efficacy and protective

ability of IgA antibodies against such diverse

pathogens as the influenza virus, Herpes simplex virus,

plague and leprosy (Ramaprasad et al., 1997; Eyles et

al., 1998; Higaki et al., 1998; Gallichan and

Rosenthal, 1998). This study extends these obser-

vations by directly demonstrating the protective effects

of IgA against an ocular pathogen. This report

demonstrates the ability of IgA to prevent infection by

a corneal pathogen. These results support the feasi-

bility of mucosal vaccines for other, more common

corneal pathogens.

Acknowledgements

We would like to thank Rolf Brekken for his excellenttechnical advice concerning hybridoma cells. We also thankDr W. Matthew Petroll for his advice and assistance on theimage capturing computers used for immunofluorescence.This work was supported in part by Grants EYO9756 andT32-AIO7520 from the National Institutes of Health,Bethesda, Maryland, and an unrestricted grant from theResearch to Prevent Blindness, New York, NY, U.S.A. DrNiederkorn is a Research to Prevent Blindness SeniorScientific Investigator.

References

Adamis, A. and Shein, O. (1994). Chlamydia andAcanthamoeba infections of the eye. In Principals andpractice of ophthalmology Vol. 1. (Albert, D. and Jakobiec,F. Eds). Pp. 179–90. W. B. Saunders Co. : Philadelphia,U.S.A..

Alizadeh, H., He, Y-G., McCulley, J. P., Ma, D., Stewart, G. L.,Via, M., Haeling, E. and Niederkorn, J. Y. (1995).Successful immunization against Acanthamoeba keratitisin a pig model. Cornea 14, 180–6.

Alizadeh, H., Niederkorn, J. Y. and McCulley, J. P. (1996).Acanthamoeba keratitis. In Ocular infection and immunity.(Pepose, J. S., Holland, G. N. and Wilhelmus, K. R. Eds).Pp. 1062–71. Mosby: St. Louis, U.S.A..

Beving, D. E., Soong, C. J. and Ravdin, J. I. (1996). Oralimmunization with a recombinant cysteine-rich sectionof the Entamoeba histolytica galactose-inhibitable lectinelicits an intestinal secretory immunoglobulin A re-sponse that has adherence inhibition activity. Infect.Immun. 64, 1473–6.

Cerva, L. (1989). Acanthamoeba culbertsoni and Naeglariafowleri. Occurrence of antibodies in man. J. Hyg.Epidemiol. Microbiol. Immunol. 33, 99–103.

Cursons, R. T. M., Brown, T. J., Keys, E. A., Moriarty, K. M.and Till, D. (1980). Immunity to pathogenic free-livingamoeba: role of humoral antibody. Infect. Immunol. 29,401–7.

Eyles, J. E., Sharp, G. J., Williamson, E. D., Spiers, I. D. andAlpar, H. O. (1998). Intranasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestissubunits confers protection from pneumonic plague inthe mouse. Vaccine 16, 698–707.

Fell, H. P., Yarnold, S., Hellstrom, I., Hellstrom, K. E. andFolger, K. R. (1989). Homologous recombination inhybridoma cells : heavy chain chimeric antibody pro-duced by gene targeting. Proc. Natl. Acad. Sci. U.S.A. 86,8507–11.

Fluckiger, U., Jones, K. F. and Fischetti, V. A. (1998).Immunoglobulins to group A streptococcal surfacemolecules decrease adherence to and invasion of humanpharyngeal cells. Infect. Immun. 66, 974–9.

Gallichan, W. S. and Rosenthal, K. L. (1998). Long-termimmunity and protection against Herpes simplex virus

84 H. LEHER ET AL.

type 2 in the murine female genital tract after mucosalbut not systemic immunization. J. Infect. Dis. 117,1155–61.

Garner, A. (1993). Pathogenesis of acanthamoebic keratitis :Hypothesis based on a histological analysis of 30 cases.Br. J. Ophthalmol. 77, 366–70.

Hazlett, L. D., Wells, P. and Berk, R. S. (1981). Immuno-cytochemical localization of IgA in the mouse cornea.Exp. Eye Res. 32, 97–104.

He, Y-G., Niederkorn, J. Y., McCulley, J. P., Stewart, G. L.,Meyer, D. R., Silvany, R. and Dougherty, J. (1990). Invivo and in vitro collagenolytic activity of Acanthamoebacastellanii. Invest. Ophthalmol. Vis. Sci. 31, 2235–40.

Hexham, J. M., Carayannopoulis, L. and Capra, J. D. (1997).Structure and function of IgA. Chem. Immunol. 65,73–87.

Higaki, M., Takase, T., Igarashi, R., Suzuki, Y., Aizawa, C.and Mizushima, Y. (1998). Enhancement of immuneresponse to intranasal influenza HA vaccine by micro-particle resin. Vaccine 16, 741–5.

Hocini, H., Belec, L., Iscaki, S., Garin, B., Pillot, J., Becquart,P. and Bomsel, M. (1997). High level ability of secretoryIgA to block HIV type I transcytosis : contrastingsecretory IgA and IgG responses to glycoprotein 160.AIDS Res. Hum. Retroviruses 13, 1179–85.

Leher, H., Alizadeh, H., Taylor, W. M., Shea, A. S., Silvany,R. S., van Klink, F., Jager, M. J. and Niederkorn, J.(1998a). Role of mucosal IgA in the resistance toAcanthamoeba keratitis. Invest. Ophthalmol. Vis. Sci. 39,2666–73.

Leher, H., Kinoshita, K., Alizadeh, H., Zaragoza, F., He, Y-G.and Niederkorn, J. (1998b). Impact of oralimmunization with Acanthamoeba antigens on parasiteadhesion and corneal infection. Invest. Ophthalmol. Vis.Sci. 39, 2337–43.

Leher, H., Silvany, R., Alizadeh, H., Huang, J. andNiederkorn, J. Y. (1988c). Mannose induces the releaseof cytopathic factors from Acanthamoeba castellanii.Infect. Immun. 66, 5–10.

Lindquist, T. D. (1998). Treatment of Acanthamoeba keratitis.Cornea 17, 11–16.

Masinick, S. A., Montgomery, C. P., Montgomery, P. C. andHazlett, L. D. (1997). Secretory IgA inhibits Pseudo-monas aeruginosa binding to cornea and protects againstkeratitis. Invest. Ophthalmol. Vis. Sci. 38, 910–18.

Niederkorn, J. Y., Ubelaker, J. E., McCulley, J. P., Stewart,G. L., Meyer, D. R., Mellon, J. A., Silvany, R. E., He,Y-G., Pidherney, M., Martin, J. H. and Alizadeh, H.

(1992). Susceptibility of corneas from various animalspecies to in vitro binding and invasion by Acanthamoebacastellanii. Invest. Ophthalmol. Vis. Sci. 33, 104–12.

Pavan-Langston, D. (1994). Viral disease of the cornea andexternal eye. In Principals and practice of ophthalmologyVol. 1. (Albert, D. and Jakobiec, F. Eds). Pp. 117–161.W. B. Saunders Co. : Philadelphia, U.S.A.

Ramaprasad, P., Fernando, A., Madhale, S., Rao, J. R.,Edward, V. K., Samson, P. D., Klatser, P. R., de Wit,M. Y., Smith, W. C. and Cree, I. A. (1997). Transmissionand protection in leprosy: indications of the role ofmucosal immunity. Lepr. Rev. 68, 301–15.

Toney, D. M. and Marciano-Cabral, F. (1998). Resistance ofAcanthamoeba species to complement lysis. J. Parasitol.84, 338–44.

van Klink, F., Alizadeh, H., He, Y-G., Mellon, J. A., Silvany,R. E., McCulley, J. P. and Niederkorn, J. Y. (1993). Therole of contact lenses, trauma, and Langerhans cells ina Chinese hamster model of Acanthamoeba keratitis.Invest. Ophthalmol. Vis. Sci. 34, 1937–44.

van Klink, F., Leher, H., Jager, M. J., Alizadeh, H., Taylor, W.and Niederkorn, J. Y. (1997). Systemic immune re-sponse to Acanthamoeba keratitis in the Chinese hamster.Ocular Immun. Inflam. 5, 235–44.

Visvesvara, G. S. and Stehr-Green, J. K. (1990). Epidemi-ology of free-living amoeba infections. J. Protozol. 37,25S–33S.

Wang, S. S. and Feldman, H. A. (1967). Isolation ofHartmonella species from human throats. N. Engl. J.Med. 277, 1174–9.

Wells, P. A. and Hazlett, L. D. (1985). Immunocytochemicallocalization of immunoglobulins at the corneal surfaceof the mouse. Exp. Eye Res. 40, 779–96.

Weltzin, R., Lucia-Jandris, P., Michetti, P., Fields, B. N.,Kraehenbuhl, J. P. and Neutra, M. R. (1989). Bindingand transepithelial transport of immunoglobulins byintestinal M cells : demonstration using monoclonal IgAantibodies against enteric viral proteins. J. Cell Biol.108, 1673–85.

Wilson, S. E., Weng, J., Blair, S., He, Y-G. and Lloyd, S.(1995). Expression of E6}E7 or SV40 large T antigen-coding oncogenes in human corneal epithelial cellsindicates regulated high-proliferative capacity. Invest.Ophthalmol. Vis. Sci. 36, 32–40.

Yang, Z., Cao, Z. and Panjwani, N. (1997). Pathogenesis ofAcanthamoeba keratitis : Carbohydrate mediated host-parasite interactions. Infect. Immun. 65, 439–45.